SNRPCP10

Across TCGA pan-cancer cohorts, SNRPCP10 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of SNRPCP10’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where SNRPCP10 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types SNRPCP10 is over-expressed in tumor, although a few such as BRCA and LUSC show the opposite, repressed pattern.

HNSC, BRCA, and STAD are the cancer types where SNRPCP10 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SNRPCP10 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	Male	II,III,IV	+0.081	.013	6	view →
BRCA	Female	II,III,IV	−0.073	.002	6	view →
STAD	All	III,IV	+0.122	.025	1	view →
LUSC	All	All	−0.078	.025	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

SNRPCP10–HNSC

Open the HNSC breakdown →